Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tenaya Therapeutics, Inc.

TNYA Clue Score23
United States Fiscal year ends December CIK 0001858848 Results filed 4 Nov 2026

What the insiders did No buying or selling

By person

6 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
David Goeddel V
Director
—
—
—
49,313,559
$35.00M
+262.6%
Faraz Ali
Chief Executive Officer
—
—
—
539,782
$383.14K
+186.6%
Whittemore Tingley
Chief Medical Officer
—
—
—
263,073
$186.73K
+106.1%
Tomohiro Higa
SVP, Finance
—
—
—
118,267
$83.95K
+15.8%
Chihiro Saito
SVP, Accounting and Fin. Ops.
—
—
—
60,983
$43.29K
−3.6%
Column Group III Gp, LP entity
10% owner
—
—
—
0
$0.00
—

No percentages here. This company's share count has moved by a factor of 2.6 over the window, from 87,582,646 to 224,230,012 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.